• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

68Ga-DOTATOC PET/CT与111In-奥曲肽SPECT/CT在神经内分泌肿瘤管理中的比较影响:一例报告。

Impact of 68Ga-DOTATOC PET/CT in comparison to 111In-Octreotide SPECT/CT in management of neuro-endocrine tumors: A case report.

作者信息

Tolomeo Anna, Lopopolo Gaetano, Dimiccoli Vincenzo, Perioli Luana, Modoni Sergio, Scilimati Antonio

机构信息

Radiopharmaceutical Division, ITEL Telecomunicazioni srl, Ruvo di Puglia.

Department of Pharmaceutical Sciences, University of Perugia, Perugia.

出版信息

Medicine (Baltimore). 2020 Feb;99(7):e19162. doi: 10.1097/MD.0000000000019162.

DOI:10.1097/MD.0000000000019162
PMID:32049844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7035109/
Abstract

RATIONALE

In the diagnostics of neuroendocrine tumors (NETs), scintigraphy and Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) with Indium-Octreotide occupy a prominent place.The introduction in clinical practice of Gallium-labelled somatostatin analogues (DOTA-TOC, DOTA-TATE, DOTA-NOC) for Positron Emission Tomography/Computed Tomography (PET/CT), significantly improved NETs diagnostics due to greater sensitivity and improved lesion detection in addition to better patient convenience and decreased radiation dose.

PATIENT CONCERNS

We report a case of a patient who was diagnosed with a neuroendocrine tumor of the ileocecal valve.

DIAGNOSES

Diagnosis was made by ultrasonography, CT, and colonoscopy. Hystology after surgery was G2 NET of ileo-cecal valve. Restaging was carried out by In-Octreotide SPECT/CT and, 1 month later, by Ga-DOTATOC PET/CT. F-FDG PET/C was also carried out.

INTERVENTIONS

Ga-DOTATOC PET/CT showed larger disease that modified disease management from surgery to medical treatment.

OUTCOMES

After an initial improvement in the patient clinical condition, the tumor caused a worsening with the appearance of ascites.

LESSONS

Ga-DOTA-conjugate PET/CT is appropriate in low and intermediate NET (Ki67 index respectively ≤3% and 3%-20%) characterized by better survival and better response after Peptide Receptor Radionuclide Therapy.F-FDG is mostly useful in high grade (G3) of disease, so that Ga-DOTA-conjugate SUV and F-FDG SUV have an opposite trend in relation to the tumor grade. Ga-DOTATOC PET/CT changes, as in our case, therapeutic management in about 40% of cases.

摘要

原理

在神经内分泌肿瘤(NETs)的诊断中,使用铟-奥曲肽的闪烁扫描法和单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)占据重要地位。用于正电子发射断层扫描/计算机断层扫描(PET/CT)的镓标记生长抑素类似物(DOTA-TOC、DOTA-TATE、DOTA-NOC)引入临床实践后,显著改善了NETs的诊断,这是因为其具有更高的敏感性,能更好地检测病变,此外还提高了患者的便利性并降低了辐射剂量。

患者情况

我们报告一例被诊断为回盲瓣神经内分泌肿瘤的患者。

诊断

通过超声、CT和结肠镜检查进行诊断。术后组织学检查显示为回盲瓣G2级NET。通过铟-奥曲肽SPECT/CT进行再分期,1个月后通过镓-DOTATOC PET/CT进行再分期。还进行了F-FDG PET/C检查。

干预措施

镓-DOTATOC PET/CT显示疾病范围扩大,从而将疾病管理从手术改为药物治疗。

结果

患者临床状况最初有所改善后,肿瘤导致病情恶化并出现腹水。

经验教训

镓-DOTA偶联物PET/CT适用于低级别和中级别的NET(Ki67指数分别≤3%和3%-20%),其特点是生存期更长,肽受体放射性核素治疗后的反应更好。F-FDG主要用于高级别(G3)疾病,因此镓-DOTA偶联物的SUV与F-FDG的SUV在肿瘤分级方面呈相反趋势。如我们的病例所示,镓-DOTATOC PET/CT在约40%的病例中改变了治疗管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c0/7035109/a685bc64798b/medi-99-e19162-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c0/7035109/0da5669f40e4/medi-99-e19162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c0/7035109/8e86d0d0a440/medi-99-e19162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c0/7035109/97e57cd6c375/medi-99-e19162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c0/7035109/a685bc64798b/medi-99-e19162-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c0/7035109/0da5669f40e4/medi-99-e19162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c0/7035109/8e86d0d0a440/medi-99-e19162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c0/7035109/97e57cd6c375/medi-99-e19162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c0/7035109/a685bc64798b/medi-99-e19162-g004.jpg

相似文献

1
Impact of 68Ga-DOTATOC PET/CT in comparison to 111In-Octreotide SPECT/CT in management of neuro-endocrine tumors: A case report.68Ga-DOTATOC PET/CT与111In-奥曲肽SPECT/CT在神经内分泌肿瘤管理中的比较影响:一例报告。
Medicine (Baltimore). 2020 Feb;99(7):e19162. doi: 10.1097/MD.0000000000019162.
2
Functional imaging in neuroendocrine tumors: assessment of molecular heterogeneity using [Ga]Ga-DOTA-TOC and [F]FDG PET/CT.神经内分泌肿瘤的功能成像:使用[镓]镓-多胺酸-奥曲肽和[氟]氟代脱氧葡萄糖PET/CT评估分子异质性
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2024 May-Jun;43(3):500011. doi: 10.1016/j.remnie.2024.500011. Epub 2024 Apr 21.
3
Ga-DOTATOC PET/CT in the localization of head and neck paraganglioma compared with F-DOPA PET/CT and I-MIBG SPECT/CT.镓-DOTATOC PET/CT 对头颈部副神经节瘤的定位与 F-DOPA PET/CT 和 I-MIBG SPECT/CT 的比较。
Nucl Med Biol. 2019 Apr;71:47-53. doi: 10.1016/j.nucmedbio.2019.04.003. Epub 2019 Apr 29.
4
Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.(68)Ga-DOTA-TOC PET/CT用于检测MEN1患者十二指肠胰腺神经内分泌肿瘤的评估
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1258-66. doi: 10.1007/s00259-016-3319-3. Epub 2016 Jan 28.
5
Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle.(68)镓-多胺基多羧基-奥曲肽与(18)氟-脱氧葡萄糖正电子发射断层显像/计算机断层扫描在接受首个完整肽受体放射性核素治疗周期的神经内分泌肿瘤患者随访中的直接比较
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1585-92. doi: 10.1007/s00259-016-3328-2. Epub 2016 Feb 27.
6
Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.68Ga-DOTATOC正电子发射断层扫描(PET)与111铟-二乙三胺五醋酸奥曲肽(Octreoscan)单光子发射计算机断层扫描(SPECT)在神经内分泌肿瘤患者中的比较。
Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1617-26. doi: 10.1007/s00259-007-0450-1. Epub 2007 May 23.
7
Clinical impact of using [F]AlF-NOTA-octreotide PET/CT instead of [Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.使用[F]AlF-NOTA-奥曲肽PET/CT而非[Ga]Ga-DOTA-SSA PET/CT的临床影响:一项多中心前瞻性试验的次要终点分析
J Neuroendocrinol. 2024 Aug;36(8):e13420. doi: 10.1111/jne.13420. Epub 2024 Jun 4.
8
Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.使用[68Ga]-DOTA-D Phe(1)-Tyr(3)-奥曲肽的正电子发射断层扫描成像与[111In]-DTPA-奥曲肽单光子发射计算机断层扫描的比较评估。神经内分泌肿瘤患者的初步结果。
Mol Imaging Biol. 2003 Jan-Feb;5(1):42-8. doi: 10.1016/s1536-1632(03)00038-6.
9
Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.68Ga-DOTATOC与68Ga-DOTATATE的患者体内定量和定性比较:用于准确量化的净摄取率
J Nucl Med. 2014 Feb;55(2):204-10. doi: 10.2967/jnumed.113.126177. Epub 2013 Dec 30.
10
Sensitivity Comparison of Ga-OPS202 and Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study.胃胰神经内分泌肿瘤患者 Ga-OPS202 与 Ga-DOTATOC PET/CT 的敏感性比较:一项前瞻性 II 期成像研究。
J Nucl Med. 2018 Jun;59(6):915-921. doi: 10.2967/jnumed.117.199760. Epub 2017 Nov 30.

引用本文的文献

1
Prospective Multicentric Assessment of Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET.镓-多他赛(Ga-DOTANOC)PET/CT对1-2级胃肠胰神经内分泌肿瘤(GEP-NET)的前瞻性多中心评估
Cancers (Basel). 2023 Jan 14;15(2):513. doi: 10.3390/cancers15020513.
2
Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience.肿瘤诱导性骨软化症的诊断与管理:临床经验视角
J Endocr Soc. 2021 Jun 2;5(9):bvab099. doi: 10.1210/jendso/bvab099. eCollection 2021 Sep 1.
3
Cost-Effectiveness Analysis of Ga DOTA-TATE PET/CT, In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors.

本文引用的文献

1
Imaging of Neuroendocrine Tumors: Indications, Interpretations, Limits, and Pitfalls.神经内分泌肿瘤的影像学表现:适应证、解读、局限性及陷阱。
Endocrinol Metab Clin North Am. 2017 Sep;46(3):795-814. doi: 10.1016/j.ecl.2017.04.008. Epub 2017 Jun 20.
2
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-DOTA-conjugated somatostatin receptor targeting peptides and F-DOPA.镓-DOTA 偶联生长抑素受体靶向肽和 F-DOPA 的神经内分泌肿瘤 PET/CT 成像指南。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1588-1601. doi: 10.1007/s00259-017-3728-y. Epub 2017 May 25.
3
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
镓 DOTA-奥曲肽 PET/CT、碘[131I]美罗曲肽 SPECT/CT 和 CT 用于神经内分泌肿瘤诊断检查的成本效益分析
Diagnostics (Basel). 2021 Feb 18;11(2):334. doi: 10.3390/diagnostics11020334.
4
Ferumoxytol-enhanced MR imaging for differentiating intrapancreatic splenules from other tumors.铁氧体增强磁共振成像在鉴别胰内副脾与其他肿瘤中的应用。
Abdom Radiol (NY). 2021 May;46(5):2003-2013. doi: 10.1007/s00261-020-02883-y. Epub 2020 Dec 30.
美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
4
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.神经内分泌肿瘤护理标准的ENETS共识指南:放射学、核医学与混合成像
Neuroendocrinology. 2017;105(3):212-244. doi: 10.1159/000471879. Epub 2017 Mar 30.
5
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.(68)镓-多柔比星和(18)氟-脱氧葡萄糖PET/CT在副神经节瘤和嗜铬细胞瘤中的应用:效用、表现形式及异质性
Cancer Imaging. 2016 Aug 17;16(1):22. doi: 10.1186/s40644-016-0084-2.
6
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
7
Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.68Ga-DOTATATE正电子发射断层扫描/计算机断层扫描用于检测胃肠胰神经内分泌肿瘤及未知原发部位的前瞻性研究
J Clin Oncol. 2016 Feb 20;34(6):588-96. doi: 10.1200/JCO.2015.64.0987. Epub 2015 Dec 28.
8
The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom.68Ga-DOTATATE PET/CT 成像对神经内分泌肿瘤患者管理的影响:来自英国国家转诊中心的经验。
J Nucl Med. 2016 Jan;57(1):34-40. doi: 10.2967/jnumed.115.166017. Epub 2015 Oct 15.
9
Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas.68Ga-DOTANOC PET/CT SUVmax 对胰腺神经内分泌肿瘤患者的预后价值。
J Nucl Med. 2015 Dec;56(12):1843-8. doi: 10.2967/jnumed.115.162719. Epub 2015 Sep 24.
10
Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation.68Ga-DOTATATE PET/CT 进行生长抑素受体显像:临床应用、正常表现、解读要点及陷阱。
Radiographics. 2015 Mar-Apr;35(2):500-16. doi: 10.1148/rg.352140164.